首页 › 癌症（所有类型） › 得克萨斯州 › Austin
Austin TX 癌症（所有类型）临床试验
22项针对 癌症（所有类型）的研究正在 Austin及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
招募中1/2 期
- NEXT Oncology ( Site 1010), Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Texas Oncology - Central/South Texas /ID# 268563, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
招募中2 期
- Dell Medical School, University of Texas at Austin, Austin
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
招募中1 期
- NEXT Texas LLC - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- USO - Texas Oncology, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
招募中3 期
- Texas Oncology, Austin
A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC
招募中1 期
- Urology Austin, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
招募中2 期
- Texas Oncology - Central/South Texas /ID# 275154, Austin
Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
招募中3 期
- Urology Austin, LLC, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- Texas Oncology - South Austin /ID# 276033, Austin
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
招募中2 期
- Texas Oncology-Austin North /ID# 279958, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
招募中1 期
- NEXT Oncology, Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- NEXT Oncology - Austin, Austin
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
招募中1 期
- Texas Oncology - Central South, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
招募中2 期
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
招募中1 期
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
招募中1/2 期
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
招募中观察性研究欢迎健康志愿者
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
招募中1/2 期
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
招募中1/2 期
- NEXT Oncology Austin, Austin
其他城市的 癌症（所有类型）试验
- Houston, TX124 项研究
- New York City, NY105 项研究
- Boston, MA90 项研究
- Los Angeles, CA73 项研究
- Nashville, TN65 项研究
- Durham, NC61 项研究
- Washington, DC60 项研究
- Philadelphia, PA57 项研究
- Arlington, VA52 项研究
- Chicago, IL51 项研究
- St. Louis, MO51 项研究
- Atlanta, GA49 项研究
Austin的其他研究
- 非小细胞肺癌29 项研究
- 肥胖症22 项研究
- 超重19 项研究
- 转移性癌症18 项研究
- 结直肠癌17 项研究
- 卵巢癌17 项研究
- 心力衰竭17 项研究
- 子宫内膜癌15 项研究
- 乳腺癌15 项研究
- 2型糖尿病14 项研究
- 前列腺癌14 项研究
- 脂肪性肝病13 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。